The company said its net sales for Q3 2025 rose 5.2% year over year to $1,320 million. Net income was $101 million ($1.97 per diluted share), compared with $137 million ($2.64 per diluted share) a year earlier.

1. 01

   The company said its net sales for Q3 2025 rose 5.2% year over year to $1,320 million. Net income was $101 million ($1.97 per diluted share), compared with $137 million ($2.64 per diluted share) a year earlier.

2. 02

   The company said adjusted EBITDA for Q3 increased to $285 million (21.6% of adjusted net sales) from $268 million (21.4%) a year earlier, and non-GAAP diluted earnings per share was $3.88, compared with $3.49 a year earlier.

3. 03

   The company said free cash flow for the first 9 months of 2025 was $504 million, calculated as net cash provided by operating activities of $560 million less capital expenditures of $56 million. It also said it made share repurchases of $284 million and the Photoneo acquisition for $62 million.

4. 04

   The company expects fourth-quarter sales growth of 8% to 11% over the prior year, and non-GAAP diluted EPS of $4.20 to $4.40 for Q4. It also plans to repurchase $500 million of its common stock over the next 12 months.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.